Basilea announces move of corporate headquarters to Allschwil, canton of Basel-Landschaft, in 2022

NEXT STORY
Press Release Oncology Venture is issuing 1,574,803 shares under its existing convertible loan note agreement with Negma Group LTD and Park Partners GP
PREV STORY
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy (“DGT”) clinical trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial

HALIFAX, Nova Scotia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Enrollment Completed for Phase 1b ...

author_avatar
NASDAQ Market News

Mayo Regional Hospital Selects Cerner CommunityWorks

DOVER-FOXCROFT, Maine, May 08, 2018 (GLOBE NEWSWIRE) -- Mayo Regional Hospital has selected Cerner, ...

author_avatar
NASDAQ Market News

Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer

GAITHERSBURG, Md., May 16, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics ...

author_avatar
NASDAQ Market News